Ativo Capital Management LLC Genmab A/S Transaction History

Ativo Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	SELL	$35.27 - $42.24 $10,545 - $12,629	-299 Reduced 1.04%	28,442 $1 Million
Q2 2023 Aug 08, 2023	BUY	$37.4 - $42.94 $1.07 Million - $1.23 Million	28,741 New	28,741 $1.09 Million
Q3 2021 Nov 12, 2021	SELL	$41.55 - $48.72 $1.42 Million - $1.66 Million	-34,096 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$32.88 - $44.57 $78,780 - $106,789	-2,396 Reduced 6.57%	34,096 $1.39 Million
Q1 2021 May 13, 2021	BUY	$30.92 - $44.4 $340 - $488	11 Added 0.03%	36,492 $1.2 Million
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $976 - $1,182	29 Added 0.08%	36,481 $1.48 Million
Q3 2020 Nov 12, 2020	BUY	$33.07 - $38.68 $1.21 Million - $1.41 Million	36,452 New	36,452 $1.33 Million

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Ativo Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ativo Capital Management LLC with notifications on news.